Monitor for the permanent CFO appointment and any potential impact on financial reporting cadence, but this filing alone is routine for a micro-cap biotech. No immediate trading catalyst.
Price Chart
Executive Summary
PDS Biotechnology Corp disclosed the resignation of CFO Lars Boesgaard, effective September 12, 2026, to pursue other professional endeavors, with no disagreement cited. The company appointed Controller Janetta Trochimiuk as interim Principal Accounting Officer and CEO Frank Bedu-Addo as interim Principal Financial Officer, effective the same date. This is a routine CFO departure with internal replacements named, carrying no material financial impact for a $12M market cap biotech.
Key Facts
- CFO Lars Boesgaard resigned effective September 12, 2026, to pursue other professional endeavors.
- Resignation is not due to any disagreement with company operations, policies, or practices.
- Janetta Trochimiuk, Controller, appointed interim Principal Accounting Officer effective September 12, 2026.
- CEO Frank Bedu-Addo appointed interim Principal Financial Officer effective September 12, 2026.
- Trochimiuk will continue at $279,519.57 annual base salary with no equity awards in connection with promotion.
Financial Impact
No material financial impact; CFO departure with internal replacements at disclosed salary of $279,519.57/year
Risk Factors
- Extended CFO vacancy could strain financial reporting if interim arrangement persists
- No permanent CFO search timeline disclosed
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-033749 |
| Document: 0001140361-26-033749-index-headers.html | 0001140361-26-033749 |
| Document: 0001140361-26-033749-index.html | 0001140361-26-033749 |
| Document: 0001140361-26-033749.txt | 0001140361-26-033749 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | 8-K | $0.3000 $0.5853 | ▼ −95.10% | ▼ −96.22% | $0.7366 (−145.53%) |
Aug 19, 2026 6w ago | 8-K | $0.2089 $0.2179 | ▲ +4.31% | ▲ +3.19% | $0.7366 (+252.61%) |
Aug 13, 2026 7w ago | 8-K | $0.2332 $0.2089 | ▲ +10.42% | ▲ +8.46% | $0.7366 (−215.87%) |
Aug 11, 2026 7w ago | 8-K | $0.2570 $0.2080 | ▲ +19.07% | ▲ +18.66% | $0.7366 (−186.61%) |
Jul 22, 2026 10w ago | EFFECT | $0.7155 $0.6696 | ▲ +6.42% | ▲ +4.01% | $0.7366 (−2.95%) |
Jun 26, 2026 13w ago | DEFA14A | $0.8991 $0.8461 | ▼ −5.89% | ▼ −7.28% | $0.7366 (−18.07%) |
Jun 15, 2026 15w ago | 8-K | $0.9600 $0.9120 | ▲ +5.00% | ▲ +2.77% | $0.7366 (+23.27%) |
Jun 15, 2026 15w ago | 8-K | $1.02 $0.9412 | ▼ −7.73% | ▼ −6.34% | $0.7366 (−27.78%) |
Jun 2, 2026 17w ago | 8-K | $1.16 $1.03 | ▼ −11.21% | ▼ −8.24% | $0.7366 (−36.50%) |
May 13, 2026 20w ago | Press Release | $1.33 $1.00 | ▼ −24.81% | ▼ −23.65% | $0.7366 (−44.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access